SOYDAL, Ç. Et Al. 2018. Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer. 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Düsseldorf, Germany).

SOYDAL, Ç., ARAZ, M., ÜRÜN, Y., Nak, D., ÖZKAN, E., & KÜÇÜK, N. Ö., (2018). Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer . 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany

SOYDAL, ÇİĞDEM Et Al. "Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer," 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 2018

SOYDAL, ÇİĞDEM Et Al. "Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany, 2018

SOYDAL, Ç. Et Al. (2018) . "Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany.

@conferencepaper{conferencepaper, author={ÇİĞDEM SOYDAL Et Al. }, title={Prognostic importance of serum PSA response in patients who received Luttetium-177 prostate specific antigen treatment for castration resistant prostate cancer}, congress name={31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Düsseldorf}, country={Germany}, year={2018}}